×
For best experience we recommend to activate Javascript in your browser.
PAFAH2 antibody (AA 1-392)
This Rabbit Polyclonal antibody specifically detects PAFAH2 in WB, IHC, IP and ICC. It exhibits reactivity toward Human.
Quick Overview for PAFAH2 antibody (AA 1-392) (ABIN7624837)
Target
See all PAFAH2 Antibodies
PAFAH2
(Platelet-Activating Factor Acetylhydrolase 2, 40kDa (PAFAH2))
Reactivity
All reactivities for PAFAH2 antibodies
Human
Host
All hosts for PAFAH2 antibodies
Rabbit
Clonality
All clonalities for PAFAH2 antibodies
Polyclonal
Conjugate
All conjugates for PAFAH2 antibodies
This PAFAH2 antibody is un-conjugated
Application
All applications for PAFAH2 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-PAFAH2 Antibody
(hide)
Binding Specificity
All epitopes for PAFAH2 antibodies
AA 1-392
Purpose
Platelet Activating Factor Acetylhydrolase 2 (PAFAH2) Polyclonal Antibody
Sequence
Met1~Leu392
Characteristics
The Platelet Activating Factor Acetylhydrolase 2 (PAFAH2) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for PAFAH2
(hide)
Target
PAFAH2
(Platelet-Activating Factor Acetylhydrolase 2, 40kDa (PAFAH2))
Alternative Name
PAFAH2
Gene ID
5051
UniProt
Q99487
Recently viewed
(hide)
Chat with us , powered by LiveChat